Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Completed · Phase 2
Conditions studied: Opioid-Related Disorders, Substance-Related Disorders
In brief
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.
Key facts
- Study ID
- NCT00000353
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 0
- Starts
- 1996-10-01
- Expected to finish
- 1997-10-01
- Last updated by the study team
- 2017-01-18
Who can join
Age: 19 and older, up to 57. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.